FindTrial
Sign In

Dermoscopy of steroid modified tinea

Clinical,dermoscopic and mycological study of steroid modified tinea

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/02/031323
Enrollment
56
Registered
2021-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

GSL medical college and general hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All clinically suspected tinea patients who have used topical steroids alone or in combination with other drugs for minimum period of 4 weeks.

Exclusion criteria

Exclusion criteria: Dermatophytic infections of hair and nail.

Design outcomes

Primary

MeasureTime frame
This study will give Clinical,dermoscopic and mycological pattern of steroid modified tinea.Timepoint: 18 months—

Secondary

MeasureTime frame
Dermoscopy will be a new emerging, fast and non invasive diagnostic tool for the diagnosis of steroid modified tinea.Timepoint: 18 months—

Countries

India

Contacts

Public ContactSwati Choudhary

GSL Medical College and General Hospital,Rajahmundry

aidsandsex@rocketmail.com9246345937

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026